Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial
拉武利珠单抗治疗既往接受过利妥昔单抗治疗的视神经脊髓炎谱系疾病(NMOSD)患者的安全性和有效性:CHAMPION-NMOSD试验的事后分析
期刊:Multiple Sclerosis Journal
影响因子:5
doi:10.1177/13524585261425076
Bennett, J L; Bhattacharyya, S; Zabeti, A; Levy, M; de Sèze, J; Taney, M J; Parks, B; Allen, K; Akpoji, U; Pittock, S J